Kailera Therapeutics, Inc. (NASDAQ:KLRA – Get Free Report) major shareholder Rtw Investments, Lp acquired 500,000 shares of the business’s stock in a transaction on Monday, April 20th. The stock was acquired at an average price of $16.00 per share, with a total value of $8,000,000.00. Following the transaction, the insider owned 10,776,820 shares in the company, valued at approximately $172,429,120. The trade was a 4.87% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Kailera Therapeutics Trading Down 3.6%
Shares of KLRA opened at $24.30 on Thursday. Kailera Therapeutics, Inc. has a 52-week low of $23.65 and a 52-week high of $28.23.
Read More
Receive News & Ratings for Kailera Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kailera Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
